(Q56882349)

English

Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention

No description defined

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention (English)

0 references

1 reference

1

David E Jones

0 references

language of work or name

English

0 references

publication date

December 2013

0 references

published in

Neurology. Clinical practice

0 references

volume

3

0 references

issue

6

0 references

page(s)

510-514

0 references

cites work

The American Academy of Neurology's top five choosing wisely recommendations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6082358

retrieved

2 November 2018

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6082358

retrieved

2 November 2018

Interferon beta for secondary progressive multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6082358

retrieved

2 November 2018

Glatiramer acetate for multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6082358

retrieved

2 November 2018

Progressive multiple sclerosis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6082358

retrieved

2 November 2018

Identifiers

DOI

10.1212/01.CPJ.0000436214.18755.AF

0 references

PMC publication ID

6082358

0 references

PubMed publication ID

30107016

0 references

(Q56882349)

Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)